← Browse by Condition
Medical Condition
endovascular treatment
Total Trials
3
Recruiting Now
3
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for endovascular treatment sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Top Sponsors
1 trial
1 trial
1 trial
NCT06179017
Recruiting
Endovascular Treatment for Mild Stroke With Acute Anterior Circulation Large Vessel Occlusion
Enrollment
300 pts
Location
China
Sponsor
Zhangzhou Municipal Hospital
NCT06772740
Recruiting
Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma
Enrollment
600 pts
Location
Japan
Sponsor
Kazutaka Uchida
NCT06464731
Recruiting
Endovascular Treatment for Mild Ischemic Stroke Due to Acute Large Vessel Occlusion in the Anterior Circulation
Enrollment
200 pts
Location
China
Sponsor
Wen-huo Chen
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology